Migraine and the Trigeminal Nervous System: The Pain Pathway Explained

The pain of migraine is not a mystery to neuroscience. The biological pathway that produces the characteristic throbbing, disabling pain of a migraine attack has been mapped in considerable detail over the past three decades, and this understanding has directly enabled the development of the most effective migraine-specific treatments available today. Central to this pathway is the trigeminal nervous system, a network of nerve fibers whose activation is the proximate cause of migraine pain.

Understanding the trigeminal system does not require a medical background. The core concepts are accessible, and they provide a framework for understanding why migraine pain feels the way it does, why it responds to certain medications and not others, and why some of the seemingly unrelated features of a migraine attack, including neck stiffness, scalp tenderness, and sensitivity to light and sound, are actually connected through the same neurological pathway.

The Trigeminal Nerve

The trigeminal nerve is the fifth cranial nerve and the largest of the twelve cranial nerves. It is responsible for sensation in the face, scalp, and meninges, the membranes that surround and protect the brain and spinal cord. It is also responsible for motor function in the muscles of chewing.

The trigeminal nerve has three main branches. The ophthalmic branch serves the forehead, eyes, and upper face. The maxillary branch serves the cheeks, upper lip, and upper teeth. The mandibular branch serves the lower jaw, lower lip, and lower teeth. All three branches converge in the trigeminal ganglion, a cluster of nerve cell bodies located near the base of the skull, before connecting to the brainstem.

Critically for migraine, the ophthalmic branch of the trigeminal nerve innervates the meningeal blood vessels, the dural sinuses, and the large cerebral blood vessels. This is why migraine pain is felt in the head rather than elsewhere in the body, and why it is often concentrated around the eye and temple.

The Trigeminovascular System

The term trigeminovascular system refers to the anatomical and functional relationship between the trigeminal nerve and the cerebral blood vessels it innervates. This system is the primary pain generator in migraine.

When the trigeminovascular system is activated during a migraine attack, the trigeminal nerve fibers surrounding the meningeal blood vessels release inflammatory neuropeptides. The most important of these is calcitonin gene-related peptide, commonly referred to as CGRP. CGRP is a potent vasodilator and neuroinflammatory agent. Its release causes the meningeal blood vessels to dilate and the surrounding tissues to become inflamed and sensitized.

This process, called neurogenic inflammation, produces the characteristic throbbing pain of migraine. The pulsating quality of the pain reflects the sensitivity of the inflamed meningeal tissues to the normal pulsations of blood flow through the dilated vessels. Each heartbeat transmits a pulse of pressure through the dilated meningeal vessels that the sensitized trigeminal fibers interpret as pain.

Central Sensitization

As a migraine attack progresses, the neuroinflammatory process that begins in the peripheral trigeminal fibers can spread to the central pain pathways in the brainstem and thalamus. This process, called central sensitization, explains several of the most disabling features of a migraine attack.

Central sensitization produces allodynia, a condition in which stimuli that are not normally painful become painful. During a migraine attack with central sensitization, light touch on the scalp, wearing glasses, combing hair, or even lying on a pillow can cause significant pain. This is not an unusual or exaggerated response. It is a predictable consequence of central sensitization affecting the pain-processing pathways connected to the trigeminal system.

Central sensitization also explains why migraine attacks become progressively harder to treat as they continue. Medications that interrupt the trigeminovascular cascade, including triptans, are most effective when taken early in the attack, before central sensitization has become established. Once central sensitization is present, these medications are significantly less effective.

CGRP and Its Significance

The identification of CGRP as a central mediator of trigeminovascular activation was a landmark in migraine research. CGRP levels in blood and cerebrospinal fluid are elevated during migraine attacks and return to baseline after effective treatment. CGRP infusion reliably triggers migraine attacks in susceptible individuals, directly demonstrating its role in migraine pathophysiology.

This understanding led to the development of CGRP monoclonal antibodies, a class of preventive medications that work by blocking either CGRP itself or its receptor. These medications represented the first class of preventive treatments developed specifically for migraine rather than repurposed from other conditions, and their clinical effectiveness reflects the accuracy of the CGRP hypothesis.

Why This Understanding Matters for Patients

Understanding the trigeminovascular mechanism has several practical implications. It explains why migraine pain is neurological rather than vascular in origin, and why treating migraine as a blood vessel problem, as was the dominant model for decades, led to treatments with limited effectiveness and significant side effects.

It explains why triptans work. Triptans are serotonin receptor agonists that constrict the meningeal blood vessels and inhibit the release of CGRP from trigeminal nerve terminals. They work because they target the trigeminovascular mechanism rather than pain in general.

And it provides a framework for understanding why migraine attacks escalate over time when untreated. The spread from peripheral to central sensitization is not inevitable. Early, effective treatment interrupts the cascade before it reaches the central nervous system, which is why the timing of treatment matters as much as the choice of treatment.